Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joyce Davidson

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 12, 2002
Factors influencing the use of thoracic radiotherapy in lung cancer--an analysis of the 1995 Scottish lung cancer auditSara C Erridge, Catherine S Thomson, Joyce Davidson, et al.
Developmental Medicine and Child Neurology|February 7, 2019
Acquired neuromyotonia in children with CASPR2 and LGI1 antibodiesSnehal Surana, Ratna Kumar, Matthew Pitt, et al.
Rheumatology (Oxford, England)|September 4, 2012
Juvenile-onset inflammatory arthritis: a study of adolescents' beliefs about underlying causeLis Cordingley, Tiffany Vracas, Eileen Baildam, et al.
The Journal of Pediatrics|September 28, 2010
Agreement between proxy and adolescent assessment of disability, pain, and well-being in juvenile idiopathic arthritisSham D Lal, Janet McDonagh, Eileen Baildam, et al.
Rheumatology (Oxford, England)|November 21, 2009
Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective StudyKimme L Hyrich, Sham D Lal, Helen E Foster, et al.
Annals of the Rheumatic Diseases|April 9, 2017
How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definitionStephanie J W Shoop-Worrall, Suzanne M M Verstappen, Eileen Baildam, et al.
Eclinicalmedicine|August 8, 2019
The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trialMadeleine Rooney, Nick Bishop, Joyce Davidson, et al.
Molecular Immunology|February 11, 2009
Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007)Mario Abinun, Terence J Flood, Andrew J Cant, et al.
Rheumatology Advances in Practice|January 11, 2019
Prevalence and course of lower limb disease activity and walking disability over the first 5 years of juvenile idiopathic arthritis: results from the childhood arthritis prospective studyGordon J Hendry, Stephanie J Shoop-Worrall, Jody L Riskowski, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of DefinitionStephanie J W Shoop-Worrall, Suzanne M M Verstappen, Janet E McDonagh, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 12, 2002
Factors influencing the use of thoracic radiotherapy in lung cancer--an analysis of the 1995 Scottish lung cancer auditSara C Erridge, Catherine S Thomson, Joyce Davidson, et al.
Developmental Medicine and Child Neurology|February 7, 2019
Acquired neuromyotonia in children with CASPR2 and LGI1 antibodiesSnehal Surana, Ratna Kumar, Matthew Pitt, et al.
Rheumatology (Oxford, England)|September 4, 2012
Juvenile-onset inflammatory arthritis: a study of adolescents' beliefs about underlying causeLis Cordingley, Tiffany Vracas, Eileen Baildam, et al.
The Journal of Pediatrics|September 28, 2010
Agreement between proxy and adolescent assessment of disability, pain, and well-being in juvenile idiopathic arthritisSham D Lal, Janet McDonagh, Eileen Baildam, et al.
Rheumatology (Oxford, England)|November 21, 2009
Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective StudyKimme L Hyrich, Sham D Lal, Helen E Foster, et al.
Annals of the Rheumatic Diseases|April 9, 2017
How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definitionStephanie J W Shoop-Worrall, Suzanne M M Verstappen, Eileen Baildam, et al.
Eclinicalmedicine|August 8, 2019
The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trialMadeleine Rooney, Nick Bishop, Joyce Davidson, et al.
Molecular Immunology|February 11, 2009
Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007)Mario Abinun, Terence J Flood, Andrew J Cant, et al.
Rheumatology Advances in Practice|January 11, 2019
Prevalence and course of lower limb disease activity and walking disability over the first 5 years of juvenile idiopathic arthritis: results from the childhood arthritis prospective studyGordon J Hendry, Stephanie J Shoop-Worrall, Jody L Riskowski, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of DefinitionStephanie J W Shoop-Worrall, Suzanne M M Verstappen, Janet E McDonagh, et al.
Pageof 3